Economy reopeningCannabis LPs need it if anything. Valuations are not the major concern imo. Sales and survival is...there can be excuse after excuse from the CEO but if he doesn’t improve sales, the CEO will be forced to sell and there goes the Hexo investment. If Canadian LPs have to count on the U.S for business, that’s a poor business model. Hexo management team will be tested in the next 24 months and we see if we have good management or poor management. The U.S or counting on the U.S legalization in the next two years is a toss of a coin. Very hard to say at this time. Hexo has top share in cannabis space, what could go wrong right? Zenabis has warrants for $118 by 4/2022